Reaction equation
Br[CH2:2]/[CH:3]=[CH:4]/[C:5]([OH:7])=O.[Cl:8][C:9]1[CH:10]=[C:11]([NH:16][C:17]2[C:22]3[C:23]4[CH2:29][CH2:28][CH2:27][NH:26][CH2:25][C:24]=4[S:30][C:21]=3[N:20]=[CH:19][N:18]=2)[CH:12]=[CH:13][C:14]=1[Cl:15].[CH3:31][NH:32][CH:33]1[CH2:35][CH2:34]1>>[CH:33]1([N:32]([CH3:31])[CH2:2]/[CH:3]=[CH:4]/[C:5]([N:26]2[CH2:27][CH2:28][CH2:29][C:23]3[C:22]4[C:17]([NH:16][C:11]5[CH:12]=[CH:13][C:14]([Cl:15])=[C:9]([Cl:8])[CH:10]=5)=[N:18][CH:19]=[N:20][C:21]=4[S:30][C:24]=3[CH2:25]2)=[O:7])[CH2:35][CH2:34]1Participants
4
Reactant 3
Product 1
Procedure
In analogy to Example 130, the title compound was prepared from (2E)-4-bromobut-2-enoic acid (127 mg, 0.62 mmol), N-(3,4-dichlorophenyl)-6,7,8,9-tetrahydro-5H-pyrimido[5′,4′:4,5]thieno[2,3-c]azepin-4-amine from Example 82A (150 mg, 0.41 mmol) and N-methylcyclopropanamine (116 mg, 1.63 mmol) to yield 21 mg (10%).
Workup
- customto yield 21 mg (10%)
Sources & evidence
- ORD record
- ord-8f5fca2e8f3b44728c6d2cc1c9ec8754
- Source dataset
- uspto-grants-2013_09
- Patent number
- US08524722B2
Linked notes
Loading…